Canada· CA-DIN-02247459

CHORIONIC GONADOTROPIN FOR INJECTION, USP

A chorionic gonadotrophin product containing chorionic gonadotropin, registered in Canada by FRESENIUS KABI CANADA LTD. The same ATC class is registered in 12 of our 19 countries.

ATC G03GA01

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about chorionic gonadotropinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Chorionic gonadotrophin is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GA01 (chorionic gonadotrophin), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
6 of them publish a price we can compare per daily dose

Search chorionic gonadotrophin products by name

Chorionic gonadotrophin · ATC G03GA01

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: CHORIONIC GONADOTROPIN
Manufacturer: FRESENIUS KABI CANADA LTD
Country: Canada (CA)
ATC code: G03GA01
ATC class: Chorionic gonadotrophin
Defined daily dose: 7.5 TSD, E
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for chorionic gonadotrophin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check chorionic gonadotrophin against other medicines How interaction checks work

Chorionic gonadotrophin · interactions on record

1 record

1 moderate

Most severe, free to view

GanirelixH01CC01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chorionic gonadotrophin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chorionic gonadotrophin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Menopur, Menopur Neo
Belgium · Menopur, Menotrophin Ferring
Bulgaria · Menopur, Менопур
Cyprus · Menopur
Czechia · Menopur, Menotrophin Ferring-Léciva
Germany · Brevactid, Menogon Hp
Denmark · Menopur
Estonia · Menopur
Spain · Menopur
Finland · Menopur
France · Menopur
United Kingdom (Northern Ireland) · Menopur
Greece · Menopur
Croatia · Menopur
Hungary · Menopur
Ireland · Menopur, Menotrophin
Iceland · Menopur
Italy · Meropur
Lithuania · Menopur
Luxembourg · Menopur, Menotrophin Ferring
Latvia · Menopur
Malta · Menopur
Netherlands · Menopur
Norway · Menopur
Poland · Menopur
Portugal · Menopur
Romania · Menopur
Sweden · Menopur
Slovenia · Menopur
Slovakia · Menopur, Menotrophin Ferring

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5a1b403d-50eb-4913-8bf0-1611cbcc0223
GET /v1/drugs/5a1b403d-50eb-4913-8bf0-1611cbcc0223?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02247459",
  "form": "POWDER FOR SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAMUSCULAR",
    "SUBCUTANEOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G03GA01",
  "schedule": [
    "Prescription",
    "Schedule D"
  ],
  "drug_code": "71705",
  "strengths": [
    "10000 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "CHORIONIC GONADOTROPIN"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about chorionic gonadotrophin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console